Cancer medicines

Atezolizumab

Atezolizumab

An immune checkpoint inhibitor targeting PD-L1.

Sources checked · Introductory guide

On this page

How it works

It blocks PD-L1-related immune suppression, helping immune cells attack cancer.[1]

Where it is used

Used alone or with other medicines in selected lung cancers, hepatocellular carcinoma and other settings.[1]

Key safety points

Report new cough, breathing difficulty, diarrhea or jaundice immediately, as well as chills or dizziness during infusion.[2]

Questions for your care team

  • Which possible immune-related symptoms require prompt contact?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Atezolizumab (opens in a new tab)
  2. MedlinePlus · Atezolizumab (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Atezolizumab | Cancer Encyclopedia | My Chemo Diary